首页> 美国卫生研究院文献>JRSM Cardiovascular Disease >P-wave dispersion: What we know till now?
【2h】

P-wave dispersion: What we know till now?

机译:纵波色散:到目前为止我们知道什么?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

P-wave dispersion is defined as the difference between the maximum and the minimum P-wave duration recorded from multiple different-surface ECG leads. It has been known that increased P-wave duration and P-wave dispersion reflect prolongation of intraatrial and interatrial conduction time and the inhomogeneous propagation of sinus impulses, which are well-known electrophysiologic characteristics in patients with atrial arrhythmias and especially paroxysmal atrial fibrillation. Extensive clinical evaluation of P-wave dispersion has been performed in the assessment of the risk for atrial fibrillation in patients without apparent heart disease, in hypertensives, in patients with coronary artery disease, in patients undergoing coronary artery bypass surgery, in patients with congenital heart diseases, as well as in other groups of patients suffering from various cardiac or non-cardiac diseases. In this paper, we aimed to summarize the measurement methods, current use in different clinical situations, strengths and limitations of the of P-wave dispersion.
机译:P波色散定义为从多个不同表面ECG导线记录的最大P波持续时间与最小P波持续时间之差。众所周知,增加的P波持续时间和P波分散反映了房内和房间传导时间的延长以及窦性冲动的不均匀传播,这是房性心律不齐,尤其是阵发性房颤患者众所周知的电生理特征。在无明显心脏病,高血压,冠状动脉疾病,冠状动脉搭桥手术的患者,先天性心脏病患者的房颤风险评估中,已进行了广泛的P波色散临床评估疾病以及患有各种心脏或非心脏疾病的其他患者组。在本文中,我们旨在总结测量方法,不同临床情况下的当前使用情况,P波色散的强度和局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号